|
CN112280828A
|
|
In vitro tissue cell nucleus separation method for reducing single cell amplification bias
|
|
CN112022854A
|
|
Application of CB-DMB in preparation of medicine for treating melanoma
|
|
CN112156110A
|
|
CD8+Application of suppressive T cells in immune regulation and induction method
|
|
CN112063681A
|
|
Chemical development toxicity prediction method, prediction model, construction method and application thereof
|
|
CN111973748A
|
|
Application of ENPP1 inhibitor and anticancer drug combined medicine in preparation of antitumor drug
|
|
WO2021031839A1
|
|
Targeted polypeptide-modified drug-loaded lipoprotein nano-drug delivery system, and preparation and application thereof
|
|
CN111777667A
|
|
Small peptide and application thereof in preparation of immunoregulation medicine
|
|
CN111697651A
|
|
Fill electric pile, autonomic mobile device, autonomic charging system
|
|
CN111450089A
|
|
Application of Bepridil or KB-R7943 in preparation of medicine for treating melanoma
|
|
CN111671906A
|
|
Application of AKR1B inhibitor in preparation of medicine for treating lung cancer
|
|
CN111713450A
|
|
Method for establishing PDX model of chronic granulocytic leukemia
|
|
CN111518808A
|
|
Three ribonucleic acid sequences with anti-tumor effect and application thereof
|
|
CN111419832A
|
|
Pharmaceutical composition and application thereof in preparing medicines for treating tumors
|
|
CN111593109A
|
|
Application of exosome miRNA biomarker and kit for rapidly diagnosing tuberculosis
|
|
CN111228222A
|
|
Nano bowl-supported drug-loaded liposome and preparation method and application thereof
|
|
CN111166885A
|
|
Neuroprotective agents and uses thereof
|
|
CN111249269A
|
|
Medical application of potassium ion channel opener
|
|
CN111048180A
|
|
Dietary intake investigation and analysis system, method and terminal
|
|
CN110734491A
|
|
Kit for detecting vibrio parahaemolyticus and detection method
|
|
CN110642757A
|
|
Compound with activation SIRT6 acetylation activity, SIRT6 agonist and application thereof
|
